Home β€Ί Stock analysis β€Ί ALVO

Alvotech (ALVO) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

ALVO slides 5.8% to $5.00, a 1-month low. Closed at $5.00, -5.84% vs the prior close of $5.31. Day range $4.95–$5.27, opened at $5.27.

Last close$5.00-5.84%
Day range4.95–5.27
Open5.27
Volume1.06M
52-week range2.94–9.00
Avg volume (20d)1.12M

ALVO daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” ALVO slides 5.8% to $5.00, a 1-month low
Oct 15, 2026 β€” ALVO rises 2.7% to $5.31
Oct 14, 2026 β€” ALVO slides 3.9% to $5.17, 3 down days in a row
Oct 13, 2026 β€” ALVO dips 2.2% to $5.38
Oct 12, 2026 β€” ALVO slides 4.8% to $5.50
Oct 9, 2026 β€” ALVO rises 1.9% to $5.78
Oct 8, 2026 β€” ALVO slides 3.1% to $5.67
Oct 7, 2026 β€” ALVO slides 4.7% to $5.85
Oct 6, 2026 β€” ALVO rises 0.5% to $6.14
Oct 5, 2026 β€” ALVO jumps 12.1% to $6.11 on 2.6x normal volume
Oct 2, 2026 β€” ALVO slides 3.0% to $5.45, 4 down days in a row

ALVO latest news & SEC filings

Every SEC filing by or about ALVO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 14, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001171843-26-006617

Oct 7, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001171843-26-006489

Oct 5, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001171843-26-006383

Aug 31, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001171843-26-005793

Aug 21, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001171843-26-005697

Aug 19, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001628280-26-057988

Jul 29, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001171843-26-004991

Jul 1, 2026 Β· Form 6-K β€” Report from a foreign company (6-K)

Report from a foreign company (6-K) β€” news it published at home

Source: SEC EDGAR filing 0001171843-26-004413

Jun 30, 2026 Β· Form SCHEDULE 13D/A β€” Update to a 13D 5%+ stake disclosure

Update to a 13D 5%+ stake disclosure

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001213900-26-073903

Things to know before you trade ALVO

ALVO market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 20265.275.274.955.001.06M
Oct 15, 20265.155.395.135.311.16M
Oct 14, 20265.325.515.155.171.05M
Oct 13, 20265.515.645.315.381.21M
Oct 12, 20265.795.895.445.50841.00K
Oct 9, 20265.675.805.575.78707.10K
Oct 8, 20265.835.835.615.67668.90K
Oct 7, 20266.106.145.845.85864.60K
Oct 6, 20266.076.176.006.141.22M
Oct 5, 20265.996.535.906.112.90M
Oct 2, 20265.615.705.435.45750.90K
Oct 1, 20265.815.825.465.621.20M
Sep 30, 20265.955.975.765.801.14M
Sep 29, 20266.146.175.825.921.17M
Sep 28, 20265.736.175.686.151.44M
Sep 25, 20265.905.905.675.75705.20K
Sep 24, 20265.756.065.755.881.20M
Sep 23, 20265.865.895.705.81774.00K
Sep 22, 20265.905.975.725.84975.90K
Sep 21, 20265.925.985.745.881.31M

About Alvotech

Alvotech (ALVO) is listed on the Nasdaq and classified by the SEC under β€œBiological Products, (No Diagnostic Substances)”. Its business address is in LUXEMBOURG, Luxembourg. State of incorporation: Luxembourg. Fiscal year ends December 31. SEC CIK 1898416.

ALVO board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Executive officers

NameTitleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Recent insider buys & sales

DateInsiderTypeSharesPrice
No open-market insider buys or sales reported in the last 12 months.

ALVO financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
No annual XBRL figures available (foreign filers often report on Form 20-F).

Latest balance sheet: total assets $β€”, total liabilities $β€”, cash $β€”.

ALVO earnings / results-day log

DateFilingClose that day
No 8-K earnings releases in recent filings.

Related stocks Β· Biological Products, (No Diagnostic Substances)

Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on ALVO

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.